Literature DB >> 16273911

Serologic responses of dogs given a commercial vaccine against Leptospira interrogans serovar pomona and Leptospira kirschneri serovar grippotyphosa.

Stephen C Barr1, Patrick L McDonough, Roberta L Scipioni-Ball, Jennifer K Starr.   

Abstract

OBJECTIVE: To evaluate serum titers obtained by use of the microscopic agglutination test (ie, MAT titers) to Leptospira interrogans serovar pomona and autumnalis and Leptospira kirschneri serovar grippotyphosa in dogs given a commercial vaccine against serovars pomona and grippotyphosa. ANIMALS: Forty 12-week-old puppies and 20 mature Beagles. PROCEDURE: Puppies received a commercial vaccine against serovars pomona and grippotyphosa at 12 weeks of age, then received a booster vaccine and 3 weeks later; mature dogs received the vaccine once. Serum MAT titers to serovars pomona, autumnalis, and grippotyphosa were measured before vaccination and at 2, 4, 6, 10, and 16 weeks after the first or only vaccination.
RESULTS: Of the 40 puppies vaccinated, 40, 0, and 40 developed MAT titers of > 100 after vaccination to serovars pomona, grippotyphosa, and autumnalis, respectively. Microscopic agglutination test titers to serovar autumnalis were higher than MAT titers to serovars pomona and grippotyphosa and persisted in some dogs for 16 weeks (6 weeks longer than for titers to serovar pomona). Of the 20 mature dogs, 13, 5, and 20 developed MAT titers of > 100 at 2 weeks to serovars pomona, grippotyphosa, and autumnalis, respectively. Titers to serovar pomona were higher and persisted in some dogs beyond 16 weeks after vaccination, compared with titers to serovars pomona and grippotyphosa, which persisted for 10 and 6 weeks, respectively. CONCLUSIONS AND CLINICAL RELEVANCE: Subunit vaccines against serovars pomona and grippotyphosa induce MAT titers not only to homologous antigens but also to serovar autumnalis, which could lead to a misdiagnosis of leptospirosis caused by serovar autumnalis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16273911     DOI: 10.2460/ajvr.2005.66.1780

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  16 in total

1.  Increase in seroprevalence of canine leptospirosis and its risk factors, Ontario 1998-2006.

Authors:  Gillian D Alton; Olaf Berke; Richard Reid-Smith; Davor Ojkic; John F Prescott
Journal:  Can J Vet Res       Date:  2009-07       Impact factor: 1.310

2.  Bacterial sepsis resulting in severe systemic illness and euthanasia in a dog with cutaneous angiomatosis.

Authors:  Kristi L Sluiter; Susan C Randell; Jessica R Ramirez; Lisa L Farina
Journal:  Can Vet J       Date:  2013-04       Impact factor: 1.008

3.  2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention.

Authors:  J E Sykes; K Hartmann; K F Lunn; G E Moore; R A Stoddard; R E Goldstein
Journal:  J Vet Intern Med       Date:  2010-12-13       Impact factor: 3.333

4.  Clinical, serological and echocardiographic examination of healthy field dogs before and after vaccination with a commercial tetravalent leptospirosis vaccine.

Authors:  Andrea M Spiri; Sabrina Rodriguez-Campos; José M Matos; Tony M Glaus; Barbara Riond; Claudia E Reusch; Regina Hofmann-Lehmann; Barbara Willi
Journal:  BMC Vet Res       Date:  2017-05-25       Impact factor: 2.741

5.  Hepatic leptospiral infections in dogs without obvious renal involvement.

Authors:  Katie E McCallum; Fernando Constantino-Casas; John M Cullen; James H Warland; Harry Swales; Niamh Linghley; Andre J Kortum; Alex J Sterritt; Tristan Cogan; Penny J Watson
Journal:  J Vet Intern Med       Date:  2018-11-29       Impact factor: 3.333

6.  Recommendations on vaccination for Latin American small animal practitioners: a report of the WSAVA Vaccination Guidelines Group.

Authors:  M J Day; C Crawford; M Marcondes; R A Squires
Journal:  J Small Anim Pract       Date:  2020-03-30       Impact factor: 1.522

7.  Molecular and serological characterization of pathogenic Leptospira spp. isolated from symptomatic dogs in a highly endemic area, Brazil.

Authors:  Cassia Moreira Santos; Gabrielle Cristini Del Rigo Santos Dias; Alexya Victória Pinheiro Saldanha; Stephanie Bergmann Esteves; Adriana Cortez; Israel Barbosa Guedes; Marcos Bryan Heinemann; Amane Paldês Gonçales; Bruno Alonso Miotto
Journal:  BMC Vet Res       Date:  2021-06-21       Impact factor: 2.741

8.  Vaccine-associated Leptospira antibodies in client-owned dogs.

Authors:  L E R Martin; K T Wiggans; S A Wennogle; K Curtis; R Chandrashekar; M R Lappin
Journal:  J Vet Intern Med       Date:  2014-03-05       Impact factor: 3.175

9.  Prospective study of canine leptospirosis in shelter and stray dog populations: Identification of chronic carriers and different Leptospira species infecting dogs.

Authors:  Bruno Alonso Miotto; Aline Gil Alves Guilloux; Barbara Furlan Tozzi; Luisa Zanolli Moreno; Aline Santana da Hora; Ricardo Augusto Dias; Marcos Bryan Heinemann; Andrea Micke Moreno; Antônio Francisco de Souza Filho; Walter Lilenbaum; Mitika Kuribayashi Hagiwara
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

10.  Reasons for Exclusion of Apparently Healthy Mature Adult and Senior Dogs From a Clinical Trial.

Authors:  Nicole H Gibbs; Hannah Michalski; Daniel E L Promislow; Matt Kaeberlein; Kate E Creevy
Journal:  Front Vet Sci       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.